Discoid lupus erythematosus (DLE, lupoid dermatosis of the nose) DLE is a sun-aggravated (and probably induced) sterile immune mediated disease that mainly affects the nasal planum of dogs (and less commonly the muzzle skin, eyelids and paws). There is likely a hereditary component to the disease as it is seen more frequently in Collies, Shetland Sheepdogs, Border Collies, and Kelpies. Diagnosis DLE is sometimes a diagnostic challenge because there are many diseases of the nose that can look similar clinically AND on histopathology. This means that biopsy alone is NOT enough confirm a diagnosis prior to commencement of therapy. What is required is a correlation of a supportive biopsy with a consistent clinical picture and (importantly) ruling out concurrent or differential diagnoses. For example, DLE may be aggravated by secondary bacterial infection and so infection must be treated before a biopsy is taken. A 2-3 week course of cephalexin at 22 mg/kg q12h immediately prior to biopsy should be done to rule out or resolve mucocutaneous bacterial pyoderma The most common reason for treatment failure is an INCORRECT DIAGNOSIS. The nasal planum is one of the most difficult areas to get a diagnostic biopsy from as there is not much tissue and lesion selection is absolutely critical. It is prudent to discuss ALL cases involving nasal planum with a dermatologist or consider referral PRIOR to biopsy collection to maximise the chance the a diagnostic sample first time. The avoids having to repeat the biopsy. Initial Therapy
Treatment for DLE varies with individuals and the severity of disease. In all cases sun avoidance between 10am and 4pm is strongly recommended, and any secondary infection should be adequately treated (if it has not already) if present prior to starting immunomodulatory therapies. Mild cases may be managed with sun avoidance alone. Vitamin E supplementation (250-500 units q12h) may also be used although we do not find much success with this. More moderate to severe cases require a more aggressive approach. If the dog will tolerate topical medication, Elidel (pimecrolimus) ointment twice daily has worked very well for us. It is a localised treatment, which is ideal, and is well tolerated and not expensive. Topical corticosteroids e.g. mometasone (Elocon) ointment may be needed early in treatment to get faster control of the crusting. Elidel does not penetrate the crusting so well initially. If a case of DLE has not responded well to topical Elidel with initial Elocon within 6 to 8 weeks, then referral is indicated. Systemic Therapy
If DLE has been confirmed by a dermatologist but topical treatment has failed then systemic treatment may be required. The next step up is doxycycline / vitamin B3 therapy. Niacinamide or nicotinamide at 250 mg q8h in small dogs < 15kg bodyweight and 500 mg q8h in larger dogs, and doxycycline at 5-10 mg/kg q24h is used, but response can take up to 6 weeks. Because of this we frequently will also use prednisolone 0.5 mg/kg once daily on a tapering dose in these initial phases of therapy to help rapidly resolve clinical lesions. These treatments are used in conjunction with Elidel and Elocon topically unless there are pet temperament issues that T: 03 9887 8844 F: 03 9887 8500 E: [email protected] W: www.melbvet.com.au Copyright 2009 Melbourne Veterinary Specialist Centre
preclude use of topicals. Long term the aim is to be able to withdraw prednisolone and taper the doxycycline to 2.5 mg/kg q24h and the vitamin B3 to q24h, or even less frequent if possible. This is important because prednisolone, while often effective for improving nasal lesions of DLE, is likely to cause iatrogenic hyperadrenocroticism with long term use at doses of > 0.25mg/kg eod (and less in some animals). If none of these therapies are effective then immunosuppression is required and management by a dermatologist recommended. Plastic surgery with removal of the dorsal nasal planum is an approach sometimes undertaken in severe cases. This surgery should only be performed by an experienced surgeon. Prognosis
Medical management in most cases is lifelong, and the disease rarely resolves permanently either spontaneously or with therapy. Some dogs will require large doses of immunosuppressive medication to achieve complete remission of clinical signs but then maintain well on more benign medication (a good outcome). It is also important to realise that depigmented regions are at risk of solar induced neoplasia (e.g. SCC) and so this is another reason to stress to owners the importance of sun avoidance. T: 03 9887 8844 F: 03 9887 8500 E: [email protected] W: www.melbvet.com.au Copyright 2009 Melbourne Veterinary Specialist Centre
Medikamentöse Behandlung der Spastik Wirkungen und Nebenwirkungen Medikamentöse Behandlung der Spastik Wirkungen und Nebenwirkungen Von Dr. rer. nat. Michael Speer , Möglichkeiten informieren. Die Wahl des faktoren (wie z.B. eingeschränkte Leber- on; Hauptarbeitsgebiet: Sichtung der internationalen medizinischen Fachliteratur auf Arzneimittelnebenwirkungen; Bearbei-
Définition Produits iod Produits iodés hydrosolubles permettant Les produits de contraste d’augmenter le contraste des structures vasculaires ou urinaires. en radiologie urinaire Deux grandes catégories: Vivien THOMSON Janvier 2004 Produits injectables Propriétés physico-chimiques Propriétés physico-chimiques OSMOLALITE OSMOLALIT